On November 20, 2023, in connection with the Dissolution, Evelo Biosciences, Inc. announced that Simba Gill ceased serving as the Company?s Chief Executive Officer, principal executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | +20.00% | -.--% | -99.02% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-99.02% | 11.39K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- Evelo Biosciences, Inc. Announces Simba Gill Ceases as Chief Executive Officer